The vast majority of older patients who have ischemia disease also have various other complications; underlying diseases such as diabetes, high blood pressure and chronic kidney disease may cause an increase in hs-cTnT values, biasing the reference standard of low hs-cTnT concentrations for ruling out AMI and/or adverse prognostic implications. This evidence concerns the gene TNNT2 and hypertensive disorder.